BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 15602552)

  • 1. Virtual screening of chemical libraries.
    Shoichet BK
    Nature; 2004 Dec; 432(7019):862-5. PubMed ID: 15602552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.
    Ma XH; Jia J; Zhu F; Xue Y; Li ZR; Chen YZ
    Comb Chem High Throughput Screen; 2009 May; 12(4):344-57. PubMed ID: 19442064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergies of virtual screening approaches.
    Muegge I
    Mini Rev Med Chem; 2008 Aug; 8(9):927-33. PubMed ID: 18691150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to benchmark methods for structure-based virtual screening of large compound libraries.
    Christofferson AJ; Huang N
    Methods Mol Biol; 2012; 819():187-95. PubMed ID: 22183538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening protocols.
    Good A
    Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrostatic-field and surface-shape similarity for virtual screening and pose prediction.
    Cleves AE; Johnson SR; Jain AN
    J Comput Aided Mol Des; 2019 Oct; 33(10):865-886. PubMed ID: 31650386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-based virtual screening protocol for drug discovery.
    Cerqueira NM; Gesto D; Oliveira EF; Santos-Martins D; BrĂ¡s NF; Sousa SF; Fernandes PA; Ramos MJ
    Arch Biochem Biophys; 2015 Sep; 582():56-67. PubMed ID: 26045247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N; Zaliani A
    J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The many roles of computation in drug discovery.
    Jorgensen WL
    Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold composition and biological relevance of screening libraries.
    Shelat AA; Guy RK
    Nat Chem Biol; 2007 Aug; 3(8):442-6. PubMed ID: 17637770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-based virtual screening to predict inhibitors against metastatic lymph node 64.
    Chitrala KN; Yeguvapalli S
    J Recept Signal Transduct Res; 2014 Apr; 34(2):92-6. PubMed ID: 24320143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling.
    Barril X; Soliva R
    Mol Biosyst; 2006 Dec; 2(12):660-81. PubMed ID: 17216047
    [No Abstract]   [Full Text] [Related]  

  • 19. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning for virtual screening (part 1).
    Ivanciuc O
    Comb Chem High Throughput Screen; 2009 May; 12(4):330-1. PubMed ID: 19442062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.